| Title : Contilistat, a new polyfunctionalized histone deacetylase inhibitor, showing potential capacity to inhibit cholinesterase\/monoamine oxidase enzymes, and modulate histamine 3, sigma 1, 5-HT6 and dopamine 3 receptors for the treatment of cancer and neurodegenerative diseases - Diez-Iriepa_2023_Chemrxiv__ |
| Author(s) : Diez-Iriepa D , Toledano-Pinedo M , Porro A , Almendros P , Rodriguez-Fernandez, MM , Samadi A , Iriepa I , Lopez-Munoz F , Artetxe-Zurutuza A , Matheu A , Marco-Contelles J |
| Ref : Chemrxiv , : , 2023 |
| Abstract : |
| PubMedSearch : Diez-Iriepa_2023_Chemrxiv__ |
| PubMedID: |
| Title : Contilistat, a new polyfunctionalized histone deacetylase inhibitor, showing potential capacity to inhibit cholinesterase\/monoamine oxidase enzymes, and modulate histamine 3, sigma 1, 5-HT6 and dopamine 3 receptors for the treatment of cancer and neurodegenerative diseases - Diez-Iriepa_2023_Chemrxiv__ |
| Author(s) : Diez-Iriepa D , Toledano-Pinedo M , Porro A , Almendros P , Rodriguez-Fernandez, MM , Samadi A , Iriepa I , Lopez-Munoz F , Artetxe-Zurutuza A , Matheu A , Marco-Contelles J |
| Ref : Chemrxiv , : , 2023 |
| Abstract : |
| PubMedSearch : Diez-Iriepa_2023_Chemrxiv__ |
| PubMedID: |
| Title : Contilistat, a new polyfunctionalized histone deacetylase inhibitor, showing potential capacity to inhibit cholinesterase\/monoamine oxidase enzymes, and modulate histamine 3, sigma 1, 5-HT6 and dopamine 3 receptors for the treatment of cancer and neurodegenerative diseases - Diez-Iriepa_2023_Chemrxiv__ |
| Author(s) : Diez-Iriepa D , Toledano-Pinedo M , Porro A , Almendros P , Rodriguez-Fernandez, MM , Samadi A , Iriepa I , Lopez-Munoz F , Artetxe-Zurutuza A , Matheu A , Marco-Contelles J |
| Ref : Chemrxiv , : , 2023 |
| Abstract : |
| PubMedSearch : Diez-Iriepa_2023_Chemrxiv__ |
| PubMedID: |